|
The Effect of Rapacuronium or Succinylcholine on the Duration of Action of Rocuronium | 
enlarge | Author: Rachael Fontanilla Publisher: Storming Media
Media: Spiral-bound Pages: 64
ISBN: 1423550528 EAN: 9781423550525
| |
| Editorial Reviews:
Product Description This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A161693. The abstract provided by the Pentagon follows: Understanding potential drug interactions of multiple drug therapy influences the induction agents chosen for an individual patient. The use of muscle relaxants is a common aspect of modern anesthesia practice. Succinylcholine, a depolarizing agent, has been used since 1952 but due has numerous adverse side effects. Non-depolarizing neuromuscular blocking agents achieve the same efficacy as succinylcholine without the adverse effects. Rocuronium, an intermediate acting non-depolarizer, provides an alternative for intubation when succinyicholine is not recommended. Rapacuronium, approved in 1999, has a shorter onset and duration of action than rocuromum. The goal of this study was to determine whether the duration of action of rocuronium is affected by the prior administration of rapacuronium or succmylcholine. Quantitative data was obtained from 30 volunteers randomly placed in two groups. For induction, Group A received succinyicholine and Group B received rapacuronium. Both groups received rocuronium for maintenance.
|
|
| Powered by Associate-O-Matic
| |